NIH Reporter #5R01AR077761-05

NIAMS Research Grant: Painless Nerve Growth Factor Therapy for Fracture Repair

This opportunity is a research grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, focused on developing painless nerve growth factor therapy for fracture repair. - Government Buyer: - National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health - OEMs and Vendors: - No specific OEMs or vendors are named; the opportunity is open to qualified research institutions - Products/Services Requested: - Research and development services to create a painless nerve growth factor therapy for accelerating endochondral fracture repair - Emphasis on translational research and biomaterials - No specific products, part numbers, or purchase quantities are listed - Unique or Notable Requirements: - Interdisciplinary collaboration is encouraged - Focus on clinically relevant therapeutic platforms for improved fracture healing - Open to eligible research organizations, not a procurement of commercial goods or services

Description

This NIH grant opportunity seeks research proposals focused on developing a painless nerve growth factor therapy to accelerate endochondral fracture repair. The project emphasizes translational research and biomaterials to create a clinically relevant therapeutic platform. It involves interdisciplinary collaboration to improve fracture healing outcomes.

View original listing